Atlas Trials

The Use of Early Pregnancy HbA1c in Predicting Excessive Fetal Growth in Women at Risk of Glucose Intolerance

Clinical trial NCT04858386 · TERMINATED

Trial details

NCT number
NCT04858386
Sponsor
Belfast Health and Social Care Trust
Status
TERMINATED
Study type
OBSERVATIONAL
Gestational Diabetes
Start date
2017-11-01
Primary completion
2020-03-21
Enrollment
1314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.